A cancer specialist discussed the FDA's approval of Johnson & Johnson’s new drug, Talvey, an antibody-based therapy for adult patients with tough-to-treat blood cancers.
In clinical studies, Talvey showed"impressive response rates" in myeloma patients who had received prior treatments, said Landgren, who is a renowned hematologist/oncologist specializing in multiple myeloma, smoldering myeloma and related plasma cell disorders."The overall response rate is 70% in patients who failed four prior lines of myeloma therapy," he said.
The most common adverse effects included an altered or impaired sense of taste, dry mouth and difficulty swallowing. , skin reactions, serious infections, low white blood cell count and low blood platelets, per the press release. "Trained health care providers know what to look for clinically and how to do lab work to monitor the individual patient’s immune status," Landgren told Fox News Digital."If everything is done correctly, these drugs are overall very safe and effective."
"Ongoing studies are seeking to define optimal ways to pre-medicate patients for the first few doses to limit side effects such as fever and immunological reactions, so these drugs can be given outpatient from day one," he said. With the large number of new, effective and safe drugs, Landgren said"the future is bright" for patients with multiple myeloma.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Red Cross implements FDA policy allowing more gay and bisexual men to donate bloodMore gay and bisexual men will be able to donate blood after the Red Cross announced Monday it would follow recent guidelines from the U.S. Food and Drug Administration.
Read more »
Another FDA Class I Recall of Cardiosave Hybrid/Rescue IABPsDatascope/Maquet/Getinge has announced a recall of the Cardiosave Hybrid and Rescue IABPs because they may shut down unexpectedly due to electrical failures in the power management board or solenoid board.
Read more »
FDA OKs Talquetamab, a First-in-Class Multiple Myeloma DrugThe FDA has granted accelerated approval to talquetamab-tgvs, a first-in-class bispecific antibody targeting the GPRC5D receptor, for heavily pretreated adults with relapsed or refractory multiplemyeloma. MedicalNews
Read more »
Listeria outbreak may be connected to recalled ice cream cups, FDA says | CNNThe US Food and Drug Administration, the US Centers for Disease Control and Prevention and local health officials are investigating a Listeria outbreak that may be connected with Soft Serve On The Go ice cream cups, the FDA said Thursday.
Read more »
Cigar industry wins court battle in challenge to FDA regulations(The Center Square) – A federal judge in Washington D.C. has blocked the U.S. Food and Drug Administration's attempt to regulate premium cigars.
Read more »
Expert: FDA's approval of first oral treatment for postpartum depression is a 'good advancFederal health officials have approved the first oral treatment for postpartum depression.
Read more »